119 related articles for article (PubMed ID: 17570703)
1. Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors.
Michalowski MB; de Fraipont F; Plantaz D; Michelland S; Combaret V; Favrot MC
Pediatr Blood Cancer; 2008 Jan; 50(1):29-32. PubMed ID: 17570703
[TBL] [Abstract][Full Text] [Related]
2. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
3. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
van Noesel MM; van Bezouw S; Salomons GS; Voûte PA; Pieters R; Baylin SB; Herman JG; Versteeg R
Cancer Res; 2002 Apr; 62(7):2157-61. PubMed ID: 11929838
[TBL] [Abstract][Full Text] [Related]
5. Clustering of hypermethylated genes in neuroblastoma.
van Noesel MM; van Bezouw S; Voûte PA; Herman JG; Pieters R; Versteeg R
Genes Chromosomes Cancer; 2003 Nov; 38(3):226-33. PubMed ID: 14506696
[TBL] [Abstract][Full Text] [Related]
6. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.
Margetts CD; Astuti D; Gentle DC; Cooper WN; Cascon A; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
Endocr Relat Cancer; 2005 Mar; 12(1):161-72. PubMed ID: 15788647
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations in sporadic basal cell carcinomas.
Stamatelli A; Vlachou C; Aroni K; Papassideri I; Patsouris E; Saetta AA
Arch Dermatol Res; 2014 Aug; 306(6):561-9. PubMed ID: 24573469
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients.
Haruta M; Kamijo T; Nakagawara A; Kaneko Y
Cancer Lett; 2014 Jun; 348(1-2):167-76. PubMed ID: 24680815
[TBL] [Abstract][Full Text] [Related]
10. Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data.
Hassan WM; Bakry MS; Siepmann T; Illigens B
Biomed Res Int; 2020; 2020():7390473. PubMed ID: 33381579
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of candidate tumor suppressor genes in neuroblastoma.
Hoebeeck J; Michels E; Pattyn F; Combaret V; Vermeulen J; Yigit N; Hoyoux C; Laureys G; De Paepe A; Speleman F; Vandesompele J
Cancer Lett; 2009 Jan; 273(2):336-46. PubMed ID: 18819746
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.
Grau E; Martinez F; Orellana C; Canete A; Yañez Y; Oltra S; Noguera R; Hernandez M; Bermúdez JD; Castel V
Mol Carcinog; 2011 Mar; 50(3):153-62. PubMed ID: 21104989
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
14. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.
Yang Q; Kiernan CM; Tian Y; Salwen HR; Chlenski A; Brumback BA; London WB; Cohn SL
Clin Cancer Res; 2007 Jun; 13(11):3191-7. PubMed ID: 17545522
[TBL] [Abstract][Full Text] [Related]
15. Association of aberrant DNA methylation with clinicopathological features in breast cancer.
Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA
Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
17. Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma.
Yagyu S; Gotoh T; Iehara T; Miyachi M; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tamura S; Tsuchiya K; Imamura T; Misawa-Furihata A; Sugimoto T; Sawada T; Hosoi H
Clin Cancer Res; 2008 Nov; 14(21):7011-9. PubMed ID: 18980997
[TBL] [Abstract][Full Text] [Related]
18. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.
Banelli B; Gelvi I; Di Vinci A; Scaruffi P; Casciano I; Allemanni G; Bonassi S; Tonini GP; Romani M
Oncogene; 2005 Aug; 24(36):5619-28. PubMed ID: 16044164
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma.
Hamilton DW; Lusher ME; Lindsey JC; Ellison DW; Clifford SC
Cancer Lett; 2005 Sep; 227(1):75-81. PubMed ID: 16051033
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
